Alpha interferon variants

Details for Australian Patent Application No. 2004280227 (hide)

Owner Biolex Therapeutics, Inc.

Inventors Gasdaska, John; Dickey, Lynn; Cox, Kevin

Agent Spruson & Ferguson

Pub. Number AU-B-2004280227

PCT Pub. Number WO2005/035767

Priority 10/675,011 30.09.03 US

Filing date 16 April 2004

Wipo publication date 21 April 2005

Acceptance publication date 19 January 2012

International Classifications

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/035767 Priority application(s): WO2005/035767

24 July 2008 Alteration of Name

  The name of the applicant has been altered to Biolex Therapeutics, Inc. 2005

19 January 2012 Application Accepted

  Published as AU-B-2004280227

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280228-Expression of biologically active polypeptides in duckweed

2004280222-Apparatus for drying a tissue web